Profusa Inc(PFSA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PFSA Profusa Inc

已收盘 06-23 16:00:00 EDT

0.1440

-0.0184

-11.33%

盘后0.1600

+0.0160+11.11%

19:59 EDT

最高0.1761	最低0.1288	成交量369.79万
今开0.1574	昨收0.1624	日振幅29.13%
总市值67.11万	流通市值61.87万	总股本466.03万
成交额57.19万	换手率86.07%	流通股本429.64万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PFSA","market":"US","secType":"STK","nameCN":"Profusa Inc","latestPrice":0.144,"timestamp":1782244800000,"preClose":0.1624,"halted":0,"volume":3697864,"hourTrading":{"tag":"盘后","latestPrice":0.16,"preClose":0.144,"latestTime":"19:59 EDT","volume":587396,"amount":91784.48617,"timestamp":1782259197577,"change":0.016,"changeRate":0.111111,"amplitude":0.170833},"delay":0,"changeRate":-0.11330049261083744,"floatShares":4296400,"shares":4660300,"eps":-48.729355,"marketStatus":"已收盘","change":-0.0184,"latestTime":"06-23 16:00:00 EDT","open":0.1574,"high":0.1761,"low":0.1288,"amount":571948.88373048,"amplitude":0.291256,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-48.729355,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1782288000000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.1624,"preHourTrading":{"tag":"盘前","latestPrice":0.1568,"preClose":0.1624,"latestTime":"09:22 EDT","volume":109555,"amount":17017.7368805,"timestamp":1782220955631,"change":-0.0056,"changeRate":-0.034483,"amplitude":0.079433},"postHourTrading":{"tag":"盘后","latestPrice":0.16,"preClose":0.144,"latestTime":"19:59 EDT","volume":587396,"amount":91784.48617,"timestamp":1782259197577,"change":0.016,"changeRate":0.111111,"amplitude":0.170833},"volumeRatio":0.441239},"requestUrl":"/m/hq/s/PFSA","defaultTab":"news","newsList":[{"id":"1145114765","title":"Profusa向Gmed提交回应文件 推进Lumee®氧气平台CE标志认证进程","url":"https://stock-news.laohu8.com/highlight/detail?id=1145114765","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145114765?lang=zh_cn&edition=full","pubTime":"2026-06-12 20:03","pubTimestamp":1781265796,"startTime":"0","endTime":"0","summary":"Profusa公司已向Gmed提交了一份回应文件，作为其Lumee®氧气平台持续进行中的CE标志认证审查流程的一部分。此举标志着该创新医疗设备在获得欧洲市场准入许可的关键步骤中取得了新的进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PFSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149373510","title":"Profusa致信股东，力促在2026年6月23日的年度股东大会上对所有提案投赞成票","url":"https://stock-news.laohu8.com/highlight/detail?id=1149373510","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149373510?lang=zh_cn&edition=full","pubTime":"2026-06-10 20:01","pubTimestamp":1781092897,"startTime":"0","endTime":"0","summary":"Profusa Inc 近日向全体股东发布了一封公开信，强烈建议并鼓励股东在即将于2026年6月23日召开的年度股东大会上，对所有提交审议的公司提案投出赞成票。\n这封致股东信函的核心目的在于，确保公司关键的战略性议案能够获得必要的股东支持，从而顺利推进。公司管理层在信中阐述了各项提案对于Profusa未来长期发展、业务规划以及提升股东价值的重要性。他们呼吁股东积极参与投票，行使股东权利，共同支持公司的决策方向，以把握未来的增长机遇。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFSA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102518557","title":"Profusa 向 Ascent Partners Fund 提交预先通知 拟通过股权额度协议购买股份 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1102518557","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102518557?lang=zh_cn&edition=full","pubTime":"2026-06-08 19:04","pubTimestamp":1780916654,"startTime":"0","endTime":"0","summary":"Profusa Inc 已根据相关证券协议，向 Ascent Partners Fund 提交了预先通知，计划依据一项股权额度安排进行股份购买。此举旨在为公司运营提供资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFSA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147765875","title":"Profusa Inc宣布启动战略评估：将探索资产层面交易、合作及并购等潜在机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=1147765875","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147765875?lang=zh_cn&edition=full","pubTime":"2026-05-05 20:33","pubTimestamp":1777984409,"startTime":"0","endTime":"0","summary":"生物传感技术企业Profusa Inc近日披露，公司正启动全面战略评估程序，旨在系统分析各类潜在发展机遇。评估范围涵盖资产层面交易、战略合作伙伴关系、业务合并以及其他可能的企业级交易方案。\n此次战略评估标志着Profusa Inc正积极寻求优化企业结构和资本配置，以提升长期价值创造能力。公司表示将审慎考察所有可行选项，确保决策符合股东利益最大化原则。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PFSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108740923","title":"Profusa Inc启动资产交易、合作伙伴关系、企业合并及其他公司交易评估流程","url":"https://stock-news.laohu8.com/highlight/detail?id=1108740923","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108740923?lang=zh_cn&edition=full","pubTime":"2026-05-05 20:31","pubTimestamp":1777984292,"startTime":"0","endTime":"0","summary":"生物科技公司Profusa Inc宣布正式启动针对资产收购、战略合作、企业合并及其他重大公司交易的评估程序。\n该评估机制将系统性地分析潜在交易机会，涵盖技术整合可行性、市场协同效应及财务影响等多维度考量。公司管理层表示，此举旨在优化资源配置，加速创新技术商业化进程。\n通过建立标准化评估框架，Profusa Inc将能够更高效地识别符合其长期发展战略的优质标的。该流程特别注重对知识产权价值、研发团队整合及监管合规性的综合评估。\n此次评估程序的规范化运作，标志着公司进入战略扩张的新阶段。未来将通过专业化团队对各类交易方案进行尽职调查与风险评估，确保决策的科学性与前瞻性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PFSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196578512","title":"Profusa启动董事会主导战略评估程序，旨在优化股东价值","url":"https://stock-news.laohu8.com/highlight/detail?id=1196578512","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196578512?lang=zh_cn&edition=full","pubTime":"2026-05-05 20:31","pubTimestamp":1777984277,"startTime":"0","endTime":"0","summary":"生物医学科技企业Profusa Inc宣布正式启动由董事会主导的战略评估程序。该举措旨在系统性地探索各类战略替代方案，以最大化公司股东价值。\n此次战略评估将全面考量包括但不限于业务合作、资本重组、资产优化等潜在路径。公司董事会表示，此决策基于对当前市场环境的审慎分析，以及对长期价值创造机遇的深入评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFSA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156475357","title":"Profusa启动董事会主导程序，评估战略选择以最大化股东价值","url":"https://stock-news.laohu8.com/highlight/detail?id=1156475357","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156475357?lang=zh_cn&edition=full","pubTime":"2026-05-05 20:31","pubTimestamp":1777984277,"startTime":"0","endTime":"0","summary":"Profusa Inc宣布正式启动由董事会主导的战略评估程序。此次行动旨在全面审视公司未来发展路径，通过系统化分析各类战略方案来优化股东回报。\n该评估流程将涵盖多项潜在战略选择，包括但不限于业务重组、资本运作及合作伙伴关系等可能性。公司董事会强调，此举是为了确保在快速变化的市场环境中把握最佳发展机遇。\nProfusa表示，战略评估委员会将由独立董事组成，确保决策过程的客观性与专业性。公司承诺将及时向投资者通报重要进展，同时保持与所有利益相关方的透明沟通。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PFSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174519209","title":"Profusa公司获3000万美元意向书，携泛组学平台进军价值数十亿美元精准诊断市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1174519209","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174519209?lang=zh_cn&edition=full","pubTime":"2026-04-06 18:01","pubTimestamp":1775469676,"startTime":"0","endTime":"0","summary":"Profusa公司宣布签署一份价值3000万美元的意向书，将正式进军规模达数十亿美元的精准诊断市场。此次战略布局的核心是公司开发的泛组学平台，该技术平台旨在通过多维度生物数据整合提升疾病诊断的精准度。此举标志着该公司在生命科学领域的业务拓展进入新阶段，有望在快速增长的精准医疗领域占据重要席位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFSA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160383899","title":"Profusa：预计自2026年第二季度起欧洲Lumee氧气产品收入将获得支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383899","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160383899?lang=zh_cn&edition=full","pubTime":"2026-02-27 22:18","pubTimestamp":1772201894,"startTime":"0","endTime":"0","summary":"生物传感技术公司Profusa Inc宣布，其欧洲市场Lumee氧气监测产品的收入预期将从2026年第二季度开始获得实质性支撑。这一进展标志着公司在推进可植入式生物传感器商业化方面迈出关键一步，为未来业绩增长注入强心针。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PFSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135738539","title":"Profusa接获Lumee™组织氧监测系统订单 上调2026年营收指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1135738539","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135738539?lang=zh_cn&edition=full","pubTime":"2026-02-19 21:31","pubTimestamp":1771507881,"startTime":"0","endTime":"0","summary":"生物传感器技术公司Profusa Inc宣布，其Lumee组织氧监测系统已获得首批采购订单。基于市场对该创新产品的强劲需求，公司同步调升了2026财年的营收预期。Lumee系统通过实时监测组织氧水平，为慢性病管理和术后康复提供精准数据支持。随着全球人口老龄化进程加剧，慢性疾病监测市场正呈现爆发式增长。Profusa的技术平台通过微型传感器与智能手机的无缝连接，有望重塑家庭健康管理生态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFSA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188558667","title":"Profusa与梅奥诊所携手推进氧监测技术的高影响力临床应用","url":"https://stock-news.laohu8.com/highlight/detail?id=1188558667","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188558667?lang=zh_cn&edition=full","pubTime":"2026-02-13 05:31","pubTimestamp":1770931874,"startTime":"0","endTime":"0","summary":"Profusa Inc与梅奥诊所宣布达成合作，共同推动氧监测技术在临床领域的深度应用。此次合作旨在开发具有高医疗价值的新型监测方案，为患者诊疗提供更精准的数据支持。\n双方将整合Profusa在生物传感器领域的创新技术，与梅奥诊所顶尖的临床研究资源，重点突破组织氧监测在慢性病管理、术后康复等场景的应用瓶颈。这项合作有望为实时生理监测领域带来突破性进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PFSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609246534","title":"Profusa, Inc.盘中异动 早盘快速下跌30.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609246534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609246534?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:33","pubTimestamp":1770301988,"startTime":"0","endTime":"0","summary":"北京时间2026年02月05日22时33分，Profusa, Inc.股票出现波动，股价急速跳水30.31%。Profusa, Inc.股票所在的医疗器械行业中，整体涨幅为0.49%。Profusa, Inc.公司简介：Profusa Inc是一家临床阶段的数字健康和医疗技术公司，专注于开发生物传感解决方案，以改善患有各种不同疾病和病症的患者的健康结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205223309a480acfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205223309a480acfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PFSA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603268684","title":"Profusa, Inc.盘中异动 急速跳水5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603268684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603268684?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:49","pubTimestamp":1768229344,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时49分，Profusa, Inc.股票出现异动，股价大幅跳水5.84%。Profusa, Inc.股票所在的医疗器械行业中，整体跌幅为0.47%。Profusa, Inc.公司简介：Profusa Inc是一家临床阶段的数字健康和医疗技术公司，专注于开发生物传感解决方案，以改善患有各种不同疾病和病症的患者的健康结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112224904a4bb1c3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112224904a4bb1c3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PFSA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600015080","title":"Profusa, Inc.盘中异动 早盘股价大跌7.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600015080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600015080?lang=zh_cn&edition=full","pubTime":"2026-01-02 22:34","pubTimestamp":1767364495,"startTime":"0","endTime":"0","summary":"北京时间2026年01月02日22时34分，Profusa, Inc.股票出现波动，股价急速跳水7.16%。Profusa, Inc.股票所在的医疗器械行业中，整体跌幅为0.20%。Profusa, Inc.公司简介：Profusa Inc是一家临床阶段的数字健康和医疗技术公司，专注于开发生物传感解决方案，以改善患有各种不同疾病和病症的患者的健康结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102223455a494ed2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102223455a494ed2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PFSA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.profusa.com","stockEarnings":[{"period":"1week","weight":-0.3127},{"period":"1month","weight":-0.5683},{"period":"3month","weight":-0.6947},{"period":"6month","weight":-0.9728},{"period":"1year","weight":-0.9998},{"period":"ytd","weight":-0.9793}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":-0.0017},{"period":"3month","weight":0.1396},{"period":"6month","weight":0.0782},{"period":"1year","weight":0.2526},{"period":"ytd","weight":0.0916}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Profusa, Inc.于2021年4月19日作为特拉华州公司注册成立。该公司是一家数字健康技术公司，开发了一种皮下生物传感器平台Lumee，旨在提供实时的个体生物化学数据。其首款产品Lumee Oxygen已获得欧盟CE认证，同时公司正在开发用于糖尿病管理的Lumee Glucose。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.026744},{"month":2,"riseRate":0.8,"avgChangeRate":-0.161283},{"month":3,"riseRate":0.8,"avgChangeRate":-0.098641},{"month":4,"riseRate":0.8,"avgChangeRate":0.03957},{"month":5,"riseRate":0.4,"avgChangeRate":-0.071937},{"month":6,"riseRate":0.6,"avgChangeRate":-0.106537},{"month":7,"riseRate":0.25,"avgChangeRate":-0.231236},{"month":8,"riseRate":0.5,"avgChangeRate":-0.099054},{"month":9,"riseRate":0.75,"avgChangeRate":-0.065332},{"month":10,"riseRate":0.25,"avgChangeRate":-0.048336},{"month":11,"riseRate":0.75,"avgChangeRate":-0.068749},{"month":12,"riseRate":0.5,"avgChangeRate":-0.086317}],"exchange":"NASDAQ","name":"Profusa Inc","nameEN":"Profusa Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Profusa Inc(PFSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Profusa Inc(PFSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Profusa Inc,PFSA,Profusa Inc股票,Profusa Inc股票老虎,Profusa Inc股票老虎国际,Profusa Inc行情,Profusa Inc股票行情,Profusa Inc股价,Profusa Inc股市,Profusa Inc股票价格,Profusa Inc股票交易,Profusa Inc股票购买,Profusa Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Profusa Inc(PFSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Profusa Inc(PFSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}